moxifloxacin has been researched along with megestrol in 2 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (megestrol) | Trials (megestrol) | Recent Studies (post-2010) (megestrol) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 1,121 | 204 | 85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
de Kam, PJ; Lillin, O; Post, T; Thomsen, T; van Kuijk, J | 1 |
1 review(s) available for moxifloxacin and megestrol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for moxifloxacin and megestrol
Article | Year |
---|---|
The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Estradiol; Female; Fluoroquinolones; Humans; Long QT Syndrome; Megestrol; Middle Aged; Moxifloxacin; Norpregnadienes; Time Factors; Young Adult | 2014 |